rBpSP-II showed sequence identity ranging from 83% to 96% to other snake venom serine proteases.
rBpSP-II showed activity on chromogenic substrates demonstrated thrombin-like activity.
rBpSP-II can serve as template for synthesis of therapeutic agents to treat hemostatic disorders.